AbbVie Deal Unmasks Promise Of Xilio’s T-Cell Engagers

Masked T-cell engagers are a buzzing field, and AbbVie’s investment has given Xilio some much-needed validation and cash as it goes up against rivals.

(Shutterstock)

More from Deals

More from Therapy Areas